Ameriprise
LFMD icon

Ameriprise’s LifeMD LFMD Stock Holding History

Ameriprise’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,483
Closed -$234K – 4160
2025
Q3 		$234K Sell
34,483
-3,026
-8% -$25K ﹤0.01% 3869
2025
Q2 		$511K Buy
+37,509
New +$354K ﹤0.01% 3524
2023
Q2 		– Sell
-14,609
Closed -$24.8K – 3962
2023
Q1 		$24.8K Sell
14,609
-942
-6% -$1.66K ﹤0.01% 3896
2022
Q4 		$30K Sell
15,551
-1,004
-6% -$2.25K ﹤0.01% 3882
2022
Q3 		$33K Sell
16,555
-28,405
-63% -$67.7K ﹤0.01% 3909
2022
Q2 		$92K Sell
44,960
-30
-0.1% -$75 ﹤0.01% 3794
2022
Q1 		$159K Sell
44,990
-1,558
-3% -$5.53K ﹤0.01% 3791
2021
Q4 		$180K Sell
46,548
-11,700
-20% -$55.3K ﹤0.01% 3805
2021
Q3 		$362K Sell
58,248
-9
-0% -$77 ﹤0.01% 3508
2021
Q2 		$686K Sell
58,257
-2,270
-4% -$26.1K ﹤0.01% 3347
2021
Q1 		$958K Buy
+60,527
New +$1.09M ﹤0.01% 3164

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Ameriprise's LFMD Position: Q4 2025 in Review

Ameriprise sold out of LifeMD (LFMD) in Q4 2025, closing a stake of 34,483 shares — an estimated $234K sold.

Ameriprise first reported a position in LFMD in Q1 2021 and held it in 11 quarters. The position peaked at $958K in Q1 2021. 104 funds tracked by Wall St. Rank hold LFMD as of Q4 2025.

  • Ameriprise reported no remaining LifeMD position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 34,483 LifeMD shares in Q4 2025, an estimated $234K.
  • Ameriprise first reported a position in LifeMD in Q1 2021 and held it in 11 quarters.
  • Ameriprise's LifeMD position peaked at $958K in Q1 2021.
  • 104 funds tracked by Wall St. Rank held LifeMD as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.